At a glance
Our 2024 Performance Overview
180.3 £m See-through Revenue*
31.5 £m Underlying Profit Before Tax
4.36p Underlying Basic EPS
180.7 £m Statutory Revenue
-14.5 £m Reported Profit Before Tax
*Non-IFRS Alternative Performance Measures (‘APMs’). See-through revenue includes all sales from Nizoral as if they had been invoiced by Alliance as principal. For statutory accounting purposes the product margin relating to Nizoral sales made on an agency basis is included within Revenue, in line with IFRS 15.
Results centreBuilt for modern business
An inter-connected network of people and brands
A global range of products delivering outstanding value. Many partners working together; one team, achieving more.